Latest filing published 23 Jul 2020 for Oncternal Therapeutics, Inc., €2.2M.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Shanghai Pharmaceutical (USA) Inc.: trading record in brief
Shanghai Pharmaceutical (USA) Inc. is a declared insider of Oncternal Therapeutics, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 7 June 2019 to 21 July 2020.
Every open-market trade on record is a purchase: 1 purchase worth €2.2M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 share grant. So far in 2020, the count stands at 1 purchase and no sales.
The newest entry dates from 23 July 2020: an open-market purchase of €2.2M, in Oncternal Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Shanghai Pharmaceutical (USA) Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,049,317 shares@ US$2.3825100.0% of flowCommon StockSEC:0000899243-20-020210:0Canonical exit: 19 Oct 2020 (T+90)
- 2,495,114 sharesCommon StockSEC:0000899243-19-016480:0
2 of 2 declarations
